Shares of Aterian Inc. (NASDAQ: ATER) skyrocketed on Tuesday, gaining nearly 89% to trade at $1.24, as the struggling consumer-products firm announced a transformative asset sale and a concurrent investment that will bring in new leadership. The company has agreed to sell its core e-commerce brand portfolio to Trademark Global LLC for $18 million in cash, while separately securing a $7 million investment from David Lazar, who is set to become the company's next chief executive officer.
The transaction carries significant weight for Aterian, which has been grappling with mounting losses and a precarious financial position. In its most recent annual filing, the company flagged "substantial doubt" about its ability to continue as a going concern, citing ongoing cash burn and operating losses. Moreover, Aterian faces a Nasdaq listing deadline in June, requiring its share price to close above $1.00 to regain compliance. Tuesday's rally pushed the stock above that threshold, though the company still faces a regulatory hurdle.
Trading volume exploded to over 189 million shares, dwarfing the company's average daily volume. The stock hit an intraday high of $1.49 before settling back slightly. With a market capitalization of roughly $12.5 million, the $18 million asset sale—before adjustments and costs—represents a substantial premium to the company's market value, underscoring the strategic importance of the deal.
The brands being sold include well-known names such as Squatty Potty, hOmeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct. Under the terms of the agreement, Trademark Global will take over global sourcing, marketing, and sales operations for these brands, along with inventory and certain liabilities. The transaction is subject to stockholder approval, with a proxy statement expected in early May and a targeted closing in the second quarter of 2026. Net proceeds to stockholders, after transaction costs, debt repayment, and working capital adjustments, are anticipated in the third quarter.
In a move to provide additional value to shareholders, Aterian plans to issue one non-transferable contingent value right (CVR) for each share of common stock. These CVRs could entitle holders to future payments tied to tariff refunds the company may receive starting in 2025, as well as proceeds from the liquidation of other assets over the next 12 months. However, the company cautioned that no dividend or CVR payment has been declared, and the final amount available for distribution could vary based on debt paydown, working capital adjustments, and closing costs.
David Lazar's $7 million investment comes in the form of convertible preferred stock, split into two tranches of $3.5 million each. The first tranche closed on April 27, while the second is contingent on stockholder approval and is expected to close concurrently with the asset sale. Lazar has joined Aterian's board and will assume the role of chief executive officer after the second tranche closes, replacing current CEO Arturo Rodriguez. Notably, Lazar and his affiliates have waived any rights to distributions from the asset sale or the CVR, signaling alignment with shareholder interests.
Arturo Rodriguez commented, "We set out in late 2025 to deliver value for shareholders and safeguard our brand portfolio. We believe that we have delivered on both counts." He added that the sale hands Aterian's brands to an experienced e-commerce supplier and distributor, providing them with a platform for further growth. Bill Kurtz, chair of Aterian's board, welcomed Lazar, saying he was "grateful for his support of our vision and investment in the Company's future."
The sale marks a strategic pivot away from the model popular during the e-commerce boom, where aggregators like Aterian and Thrasio snapped up online marketplace brands to scale them. Thrasio itself filed for bankruptcy in 2024 before restructuring. Aterian's 2025 financial results underscore the challenges: net revenue fell 30.4% to $69.0 million from $99.1 million in the prior year, driven by new tariffs, higher prices, and weaker demand at elevated price points. The net loss widened to $19.0 million from $11.9 million.
Following the sale, Aterian plans to retain a handful of smaller legacy brands, including Vremi and Xtava. Details on Lazar's strategic vision for the remaining business remain limited. The company expects to file a Form 8-K with the U.S. Securities and Exchange Commission around April 29, providing further details on the transactions.
